Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
108 participants
INTERVENTIONAL
2025-01-06
2028-07-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this study is to compare the CARES program for adolescents alone to the CARES program for adolescents combined with a parent group using Non-Violent Resistance (NVR) on the occurrence of self-harming behaviors among adolescents who have engaged in suicidal acts and/or have active suicidal ideation, six months after the conclusion of the intervention.
This is a prospective, randomized, open-label, single-center, controlled study with two parallel arms, with blinded assessment of the outcome measures.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mixed-method Evaluation of a Parental Psychoeducation Programme in a Suicide Risk Prevention Group
NCT06576453
Alliance With Therapeutic Entourage in Support of Young Suicidal
NCT02524535
Qualitative Study of Suicidal Recrudescence Among Adolescents in November 2021
NCT05795894
Exploratory Analysis of Interpersonal and Intrapersonal Psychological Processes Implied in Risk-taking and Suicidal Behaviors, in Adult and Adolescent At-risk
NCT06921226
Evaluation of the Risk Associated With Impulsivity and Other Neuropsychological Factors on Suicidal Relapse Within Hospital Emergencies
NCT03026387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The CARES adolescent and NVR parent program includes the same adolescent group described above, supplemented by an NVR parent group. This parent group meets once a week for one month (4 sessions), with two additional booster sessions at 1 month and 3 months post-intervention. The content of the parent program is a parent management training composed of strategies for managing their adolescent's emotional crises through emotional regulation techniques based on Non-Violent Resistance (NVR) methods (Omer, 2021).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adolescent group therapy (CARES) and parent group therapy (RNV)
In the adolescent group, they will attend 8 group sessions during 1 month (2 sessions/week). There also will be a "boost" session 3 month after the last session.
Parents will attend 4 group sessions during 1 month too (1 session/week). There will be 2 "boost" sessions : 1 month and 3 month after the last session
Patients will be randomized in each group with blinded assessment
Adolescent group therapy (CARES) and parent group therapy (RNV)
In the adolescent group, they will attend 8 group sessions during 1 month (2 sessions/week). There also will be a "boost" session 3 month after the last session. Parents will attend 4 group sessions during 1 month too (1 session/week). There will be 2 "boost" sessions : 1 month and 3 month after the last session Patients will be randomized in each group with blinded assessment
Adolescent groupe therapy (CARES) only
In the adolescent group, they will attend 8 group sessions during 1 month (2 sessions/week).
There will be a "boost" session 3 month after the last session
Patients will be randomized in each group with blinded assessment
Cognitive behavioral group therapy for adolescents and non violent resistance group for parents
In the adolescents group, this cognitive-behavioral group therapy will include emotion regulation skills, distress tolerance skills, cognitive strategies, work on values and problem-solving strategies
Those sessions will include psychoeducation about adolescents, about suicidal ideation and suicidal behavior, coping with adolescent emotional distress, support on how to be a parent today (screen regulation...) and manage daily life
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive behavioral group therapy for adolescents and non violent resistance group for parents
In the adolescents group, this cognitive-behavioral group therapy will include emotion regulation skills, distress tolerance skills, cognitive strategies, work on values and problem-solving strategies
Those sessions will include psychoeducation about adolescents, about suicidal ideation and suicidal behavior, coping with adolescent emotional distress, support on how to be a parent today (screen regulation...) and manage daily life
Adolescent group therapy (CARES) and parent group therapy (RNV)
In the adolescent group, they will attend 8 group sessions during 1 month (2 sessions/week). There also will be a "boost" session 3 month after the last session. Parents will attend 4 group sessions during 1 month too (1 session/week). There will be 2 "boost" sessions : 1 month and 3 month after the last session Patients will be randomized in each group with blinded assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Active suicidal ideation and/or suicidal behavior during the last 6 months
* The patient is referred by a healthcare professional
Exclusion Criteria
* Non-french speaking
* Planned travel not allowing the complete following of the study
* The patient, the parents or the legal guardian can not be correctly informed
* The patient presents symptoms that prevent him from group interaction (behavior disorders, hallucinations, delirium)
* The family already followed the same kind of program
* The patient is already enrolled in a clinical trial or is taking a treatment off full market approval during 4 weeks before screening
* The patient and the family are not affiliated to any healthcare insurance
* No signed consent from parents or a legual guardian nor one of the parental authority holder
* The patient did not consent
12 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL22_0339 / UF 8379
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.